MetaCap

Mobia Medical (MOBI) vs Senseonics (SENS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Senseonics is the larger company by market cap ($439.3 million vs $394.5 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MOBI+0.85%SENS+59.44%
+124%+43%-39%
May 8, 20261 yearNov 20, 2026
MOBI+0.85%SENS+59.44%
+117%+40%-38%
May 4, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MOBI versus SENS key metrics
MetricMOBISENS
Share price$11.85$8.02
Market cap$394.50M$439.34M
1-day change-0.08%-9.94%
YTD return—+45.29%
1-year return—+49.91%
5-year return—-87.59%
EPS (TTM)$-1.75$-2.27
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$35.26M
Revenue growth (YoY)—+56.89%
Net income (latest FY)—$-69.10M
Gross margin—44.71%
Operating margin—-193.83%
Net margin—-195.99%
52-week high$15.29$13.98
52-week low$8.03$4.79
Distance from 52-week high-22.50%-42.62%
Analyst consensusnonebuy
Avg. price target upside+51.90%+88.03%
Average volume214.96K821.73K
Shares outstanding33.29M54.78M
Employees167130
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Mobia Medical

MOBI stock →

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.

Health Care · Medical/Dental Instruments · 167 employees

About Senseonics

SENS stock →

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.

Health Care · Medical/Dental Instruments · 130 employees

MOBI vs SENS FAQ

Which is bigger, Mobia Medical or Senseonics?

Senseonics (SENS) is larger, with a market capitalization of $439.34M compared with $394.50M for Mobia Medical (MOBI).

Are Mobia Medical and Senseonics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons